3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
2
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Precancerous Conditions
1
Neoplasms, Second Primary
1
Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Fibrosis
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Adenomatous Polyps
1
Interventions
Fluorouracil
61
Leucovorin
56
Oxaliplatin
51
Capecitabine
42
Irinotecan
29
Bevacizumab
21
Radiotherapy
17
Cetuximab
12
Folfox protocol
11
Chemoradiotherapy
11
Neoadjuvant Therapy
10
Chemotherapy, Adjuvant
9
Surgical Procedures, Operative
6
Drug Therapy
6
XELOX
5
Panitumumab
4
Laparoscopy
4
FOLFOXIRI protocol
4
Transanal Endoscopic Microsurgery
3
Radiation
3
Octreotide
3
IFL protocol
3
Floxuridine
3
Diathermy
3
Celecoxib
3
vatalanib
2
spartalizumab
2
Trinitrotoluene
2
Tegafur
2
Semaxinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Rectal Neoplasms
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts